Introduction
============

Hearing loss (HL) is a sensory deficit that is becoming a severe social and health problem. It can also lead to impaired verbal language processing, thereby limiting meaningful communication and social connectivity. Such communication difficulties negatively affect work productivity and cognitive and emotional statuses.[@b1-dmso-10-459] The increase in the prevalence of HL may be due to the aging of the population and exposure to noise

There is an association between the risk factors of cardiovascular disease and age-associated HL in adults.[@b2-dmso-10-459] The environmental factors related to HL have been studied. HL associated with noise exposure is sensorineural, bilateral, and symmetrical, and it is likely that irreversible hearing impairment gradually develops over a period of 5--20 years by general exposure at all different locations.[@b3-dmso-10-459] Individuals with this condition likely have a prolonged history of exposure to noise, which has caused a notch configuration at 3--6 kHz on a pure tone audiogram, most often caused by steady-state noise exposure, although impulse noise is more detrimental.[@b4-dmso-10-459] It has been estimated that \~600 million workers worldwide, 10% of the total American population and 20% of the European workers, are exposed to hazardous noise levels at work.[@b5-dmso-10-459],[@b6-dmso-10-459] In addition to environmental factors, it is suggested that several medical risk factors have an influence on hearing. Some components of the metabolic syndrome (MetS) coincide with risk factors associated with sensorineural hearing loss (SNHL), such as increased blood pressure, hyperlipidemia, and low level of high-density lipoprotein. Hyperlipidemia impairs the morphology and function of the cochlea.[@b7-dmso-10-459],[@b8-dmso-10-459] The MetS increases the risk of cardiovascular events and progression to diabetes mellitus.[@b9-dmso-10-459]--[@b11-dmso-10-459] Interestingly, there is an association between high-frequency sensorineural hearing impairment and diabetes mellitus.[@b12-dmso-10-459],[@b13-dmso-10-459] The pathophysiological mechanisms of the relationship between MetS and HL are poorly understood.[@b14-dmso-10-459] To date, only a few studies have specifically addressed the role of MetS in HL, and little effort has been made to examine the relationship between MetS and HL. The present study was conducted to assess the relationship between MetS and HL in a population of professional drivers from the West Azerbaijan province.

Methods
=======

Ethics statement
----------------

The study protocol was approved by the ethics committee of Medical Sciences at the Urmia University, and participants provided written informed consent at recruitment.

Study population
----------------

Between 2014 and 2016, the Iranian Health Department conducted a series of surveys among professional drivers of commercial motor vehicles. During this 2-year period, more than 24,000 individuals, who operated motor vehicles over long distances, were referred to the occupational medicine center for a fitness to work assessment. All drivers were men and residents of the West Azerbaijan province of Iran. Of the participants who participated in this cross-sectional study, half of them aged between 20 and 60 years were selected for an audiometric assessment. From the total of 24,277 participants, a random selection of 12,138 participants was made for this hearing test. This number was reduced to 11,114 participants by exclusion criteria.

Written consent to participate in the research study was obtained from each participant. The participants were asked to complete a comprehensive questionnaire on basic information about their demographics, medical history, medication use, and social and family history.

Exclusion criteria
------------------

The questionnaire, audiometric tests, and otoscopic examinations were assessed, and participants were excluded if they met any of the following criteria: unreliable audiometric measurements (i.e., there was a 10 dB difference between the 1000 Hz test and retest thresholds \[n=547\]), nonresponse code to audiometric testing (n=79), and a history of ear surgery, ototoxic drug use (such as cisplatin or aminoglycosides), severe or frequent ear infection, hypothyroidism, and/or unilateral (difference between ears in air conduction threshold was \>40 dB for at least two frequencies at 500, 1000, and/or 2000 Hz) or conductive HL (n=398).

Audiometric measurements
------------------------

The hearing acuity assessments were performed by a qualified audiologist using a diagnostic audiometer (Model AD 229e; Interacoustic Denmark Co. Ltd.) in an isolated acoustic room. All tests met the requirements of ANSI S3.1-1991. Standardized audiometric procedures were applied assuring at least 14 hours of noise avoidance by the participants.

The pure tone conduction hearing thresholds for the left and right ears were measured at 500, 1000, 2000, 3000, 4000, 6000, and 8000 Hz over an intensity range of −10 to 120 dB. The pure tone average (PTA) at 500, 1000, and 2000 Hz was defined as low PTA, while the PTA at 3000, 4000, 6000, and 8000 Hz was defined as high PTA.

In this study, sensorineural hearing impairment was defined with the following criteria: the difference in the threshold at the frequency of 4000 and 1000 Hz was \>30 dB, or the hearing threshold at 4000 Hz in the ear with better hearing was \>25 dB.

The hearing assessment was performed twice in each ear at the frequency of 1000 Hz to verify the reliability of each participant's responses. The impaired audiometric configurations were classified according to one of three pattern types: flat, down-sloping, and noise-induced high-tone loss. The criteria that were applied to determine the various audiometric configurations were as follows: Flat: transgression of hearing threshold at all frequencies was \>25 dB HL, but the difference between the average at the lower two (1000 and 2000 Hz), mid two (3000 and 4000 Hz) or upper two (6000 and 8000 Hz) frequencies was \<10 dB HL.Down-sloping: the average of thresholds at the higher two frequencies (6000 and 8000 Hz) was ≥10 dB HL than that at the mid two frequencies (3000 and 4000 Hz), but the difference between the average at the lower two (1000 and 2000 Hz) and mid two frequencies (3000 and 4000 Hz) was \<10 dB HL.Noise-induced high-tone loss: elevated thresholds were observed in the 3000--6000 Hz region of the audiogram with HL at frequencies of 3000--6000 Hz at least 10 dB worse than the worst hearing threshold values at 500 or 1000 Hz, and hearing thresholds at 8000 Hz were at least 10 dB better than the worst threshold at 3000, 4000, or 6000 Hz.

Definition of MetS
------------------

All participants were screened for MetS using International Diabetes Federation criteria that consisted of the presence of central adiposity on the basis of waist circumference ≥94 cm plus two or more of the following four factors: concentration of triglycerides (TGs) ≥150 mg/dL (1.7 mmol/L), concentration of high-density lipoprotein cholesterol (HDL-c) \<40 mg/dL (1.03 mmol/L), systolic blood pressure ≥130 mmHg or diastolic blood pressure ≥85 mmHg, and fasting blood glucose (FBG) concentration ≥100 mg/dL (5.6 mmol/L).[@b15-dmso-10-459]

Evaluation of potential risk factors
------------------------------------

Anthropometric and clinical data were obtained using physical examinations, as previously described.[@b16-dmso-10-459],[@b17-dmso-10-459] Briefly, all participants were required to fast overnight before blood sampling and blood pressure measurements were performed. At each visit, data on blood pressure, anthropometric measures (e.g., waist circumference, height, and weight), and routine laboratory measures (e.g., FBG, TG, and HDL-c) were collected. Body mass index (BMI) was calculated as the ratio of weight and squared height. In accordance with the criteria of the World Health Organization, normal weight was defined as BMI \<25 kg/m^2^, overweight as BMI ≥25 kg/m^2^, and obesity as BMI ≥30 kg/m^2^.

A complete smoking history was also evaluated that included the number of years the patient had been smoking and the average number of cigarettes smoked per day. Smoking pack-years were calculated, and the participants were allocated into one of four smoking categories: non-smoker, ≤10 smoking pack-years, 11--20 smoking pack-years, and \>20 smoking pack-years.

Statistical analysis
--------------------

All statistical analyses were performed using SPSS, version 20. Quantitative measurements were expressed as the mean and standard deviation. Qualitative variables were presented as absolute frequency and percentage. Logistic regression was used to analyze the association of various risk factors with SNHL and to identify the relationship. Linear regression was used to analyze the relationship between MetS and PTA hearing threshold. The correlation between various components of MetS and SNHL was measured using Spearman's correlation coefficient. A *P*-value of \<0.05 was considered as significant.

Results
=======

We enrolled 11,114 professional drivers in this study. Of these, 3202 (28.81%) were diagnosed with MetS and 7911 (71.18%) without MetS and 2772 (24.94%) with SNHL and 8432 (75.86%) without SNHL. The quantitative and qualitative characteristics of participants are summarized in [Table 1](#t1-dmso-10-459){ref-type="table"}.

[Table 1](#t1-dmso-10-459){ref-type="table"} shows that the participants with SNHL were older; had a higher BMI; had higher levels of FBG, TG, HDL-c, and low-density lipoprotein cholesterol; had higher systolic blood pressure, diastolic blood pressure, and waist circumference; and had longer duration of driving than those without SNHL.

The association of various potential risk factors on SNHL was investigated by calculating odds ratios (ORs). There were statistically significant differences in the following risk factors between participants with and without SNHL: MetS, hypertension, smoking, BMI, age, and duration of driving ([Table 2](#t2-dmso-10-459){ref-type="table"}).

[Table 3](#t3-dmso-10-459){ref-type="table"} shows that in addition to MetS, other potential risk factors, such as BMI, smoking, and duration of driving, are also significantly associated with different categories of SNHL.

[Table 4](#t4-dmso-10-459){ref-type="table"} shows that the β coefficients of hearing threshold of participants with MetS were 0.060 in the unadjusted model and 0.051 (Model 1) and 0.059 (Model 2) in the adjusted mode for the high PTA and 0.006 in the unadjusted model and 0.005 (Model 1) and 0.005 (Model 2) in the adjusted mode for the low PTA.

Discussion
==========

This cross-sectional study is one of the first studies to investigate the association between MetS and SNHL and reports on a novel finding regarding this association. By analyzing data on 11,114 drivers of the West Azerbaijan province, we found that 28.81% of them met the criteria for MetS. This ratio was higher than the values that were previously reported by other authors.[@b18-dmso-10-459],[@b19-dmso-10-459] One of the reasons for this difference is the drivers' lifestyle, making them more likely to develop MetS components. Another reason for high prevalence in this study might be sampling bias (all of including population was professional drivers).

The prevalence of 24.94% for SNHL in the present study is slightly higher than reported in other studies.[@b18-dmso-10-459],[@b19-dmso-10-459] Differences in reported prevalence are most likely due to the sample size of the study, different criteria for the diagnosis, or genetics.

We found a strong association between different components of MetS (obesity, hypertension, hypertriglyceridemia, high fasting glucose levels, and waist circumference) with SNHL. As mentioned in the Results section, the risk of having SNHL in individuals with MetS compared to participants without MetS was 1.40 (95% confidence interval \[CI\]: 1.28--1.54). Compared to all the three categories of the SNHL, the OR for MetS with four components was 1.48 (95% CI: 1.28--1.71) and that for MetS with five components was 1.78 (95% CI: 1.30--2.44). This finding shows that MetS is a risk factor for SNHL, and with an increase in the number of MetS components, the risk of HL was also increased. On the other hand, MetS as a risk factor for different categories of SNHL should also be considered ([Table 3](#t3-dmso-10-459){ref-type="table"}).[@b17-dmso-10-459] This issue needs further investigation in separate studies by other researchers.

Univariate and multivariate linear regression analyses showed that low PTA and high PTA thresholds were positively associated with MetS. Interestingly, after adjusting for objective confounders including age, duration of driving as a marker of noise exposure, and smoking in Model 1 and confounders in Model 1 and BMI in Model 2, there is a trend in the β coefficients of hearing threshold in the presence of MetS ([Table 4](#t4-dmso-10-459){ref-type="table"}).

Another important finding is the relationship between HL and hypertension. The OR of SNHL for individuals with hypertension was 1.61 (95% CI: 1.48--1.76) compared to individuals with normal blood pressure. Although the mechanisms that underlie this relationship are poorly understood, Duck et al[@b20-dmso-10-459] have shown that hypertension potentially interacts with diseases like diabetes mellitus and therefore plays a role in the pathogenesis of SNHL.

Driving duration as an indicator of long-term exposure to noise and vibration may play a key role in hearing impairment. Our data strongly support that an increase in the number of driving years increases the risk of HL. The OR for SNHL for those who had 10--20 driving years was 2.20 (95% CI: 1.91--2.53) compared to drivers who had \<10 driving years, and the OR in those who had \>20 driving years was 5.85 (95% CI: 5.14--6.66) compared to participants with \<10 driving years. This issue requires a separate investigation.

Our findings in [Table 2](#t2-dmso-10-459){ref-type="table"} strongly support the relationship between smoking and HL. By increasing the number of cigarettes pack-years by professional drivers, their risk of HL increases. Indeed, several studies revealed a significant association between tobacco smoking and HL.[@b21-dmso-10-459]--[@b23-dmso-10-459] The best predictor for NSHL of the anthropometric indices that results in the MetS remains unknown, but our results together with a report by Curhan et al[@b24-dmso-10-459] suggest that being overweight and obese is associated with SNHL. Some studies showed associations between hearing impairment and BMI, with BMI as a classical indicator of obesity. The authors suggested that by increasing BMI, the risk of HL is increased.[@b25-dmso-10-459],[@b26-dmso-10-459]

This study had some limitations. First, it was a cross-sectional study, and therefore, the evaluation of the relationship between the past exposure and the current outcome was weak. Prospective analysis, which includes follow-up data, is required to confirm the correlations between MetS and SNHL that were identified in this study. Second, the effect of recall bias on the data on habitual parameters, such as the number of cigarette packs smoked and pack-years, cannot be excluded.

Conclusion
==========

In summary, our results demonstrated that an association possibly exists between MetS components to predicting hearing impairment.
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###### 

Characteristics of participants with and without SNHL

  Variables                                                               SNHL            *P*-value       
  ----------------------------------------------------------------------- --------------- --------------- ---------
  Continuous variables, mean ± SD                                                                         
   Age (years)                                                            43.45±10.07     36.05±9.26      \<0.001
   BMI (kg/m^2^)                                                          27.17±4.08      26.42±4.13      \<0.001
   FBG (mg/dL)                                                            94.05±22.71     90.37±19.18     \<0.001
   TG (mg/dL)                                                             181.60±118.87   170.88±114.17   \<0.001
   HDL cholesterol (mg/dL)                                                45.05±9.78      43.99±9.58      \<0.001
   Total cholesterol (mg/dL)                                              186.48±37.12    183.09±38.01    \<0.001
   Systolic blood pressure (mmHg)                                         126.85±16.37    123.29±13.81    \<0.001
   Diastolic blood pressure (mmHg)                                        80.52±10.38     76.96±10.18     \<0.001
   Waist circumference (cm)                                               95.21±11.56     92.42±11.94     \<0.001
   Duration of driving (years)                                            28.06±6.52      26.04±5.39      \<0.001
   Left ear (dB)                                                                                          
    Low PTA                                                               12.65±6.25      6.85±2.81       \<0.001
    High PTA                                                              33.86±14.50     9.61±4.69       \<0.001
   Right ear (dB)                                                                                         
    Low PTA                                                               12.50±6.07      6.76±2.67       \<0.001
    High PTA                                                              32.69±14.82     9.29±4.27       \<0.001
  Qualitative variable, n (%)                                                                             
   Smoking status                                                                                         
    Nonsmoking                                                            1951 (70.4)     6761 (81.0)     --
    ≤10 pack-years                                                        360 (13.0)      976 (11.7)      --
    11--20 pack-years                                                     285 (10.3)      402 (4.8)       --
    \>20 pack-years                                                       176 (6.3)       203 (2.4)       --
    Hypertension $\left( {\frac{\geq 130}{\geq 85}\text{mmHg}} \right)$                                   
    Yes                                                                   1293 (46.6)     2927 (35.1)     --
    No                                                                    1479 (53.4)     5415 (64.9)     --
    BMI                                                                                                   
    Normal weight (BMI\<25 kg/m^2^)                                       883 (31.9)      3273 (39.2)     --
    Overweight (25≤BMI≤29 kg/m^2^)                                        1209 (43.6)     3418 (41.0)     --
    Obesity (BMI≥30 kg/m^2^)                                              680 (24.5)      1651 (19.8)     --

**Abbreviations:** SNHL, sensorineural hearing loss; SD, standard deviation; BMI, body mass index; FBG, fasting blood glucose; TG, triglyceride; HDL, high-density lipoprotein; low PTA, pure tone average at low frequencies; high PTA, pure tone average at high frequencies.

###### 

Associations between various potential risk factors and SNHL (yes/no)

  Variables                                    OR (95%CI)          *P*-value   Adjusted OR (95% CI)                                           *P*-value
  -------------------------------------------- ------------------- ----------- -------------------------------------------------------------- -----------
  MetS (yes/no)                                1.40 (1.28--1.54)   \<0.001     1.38 (1.25--1.51)[a](#tfn2-dmso-10-459){ref-type="table-fn"}   \<0.001
  MetS (with 4 components/with 3 components)   1.48 (1.28--1.71)   \<0.001     1.45 (1.26--1.67)[a](#tfn2-dmso-10-459){ref-type="table-fn"}   \<0.001
  MetS (with 5 components/with 3 components)   1.78 (1.30--2.44)   \<0.001     1.72 (1.25--2.37)[a](#tfn2-dmso-10-459){ref-type="table-fn"}   \<0.001
  Hypertension (yes/no)                        1.61 (1.48--1.76)   \<0.001     1.58 (1.45--1.72)[a](#tfn2-dmso-10-459){ref-type="table-fn"}   \<0.001
  Smoking (yes/no)                             1.50 (1.37--1.65)   \<0.001     1.37 (1.25--1.51)[b](#tfn3-dmso-10-459){ref-type="table-fn"}   \<0.001
  Smoking (≤10 pack-years/nonsmokers)          1.27 (1.12--1.45)   \<0.001     1.19 (1.04--1.37)[b](#tfn3-dmso-10-459){ref-type="table-fn"}   \<0.001
  Smoking (11--20 pack-years/nonsmokers)       2.45 (2.09--2.88)   \<0.001     1.58 (1.33--1.87)[b](#tfn3-dmso-10-459){ref-type="table-fn"}   \<0.001
  Smoking (\>20 pack-years/≤ nonsmokers)       3.00 (2.44--3.69)   \<0.001     2.33 (2.07--2.66)[b](#tfn3-dmso-10-459){ref-type="table-fn"}   \<0.001
  BMI (overweight/normal weight)               1.31 (1.18--1.44)   \<0.001     1.33 (1.20--1.47)[a](#tfn2-dmso-10-459){ref-type="table-fn"}   \<0.001
  BMI (obesity/normal weight)                  1.52 (1.35--1.71)   \<0.001     1.55 (1.38--1.75)[a](#tfn2-dmso-10-459){ref-type="table-fn"}   \<0.001
  Age (35--49/20--34 years)                    2.67 (2.37--3.01)   \<0.001     2.58 (2.29--2.91)[a](#tfn2-dmso-10-459){ref-type="table-fn"}   \<0.001
  Age (≥50/20--34 years)                       6.94 (6.08--7.92)   \<0.001     6.35 (5.54--7.27)[a](#tfn2-dmso-10-459){ref-type="table-fn"}   \<0.001
  Driving period (10--20/\<10 years)           2.20 (1.91--2.53)   \<0.001     2.17 (1.89--2.49)[a](#tfn2-dmso-10-459){ref-type="table-fn"}   \<0.001
  Driving period (\>20/\<10 years)             5.85 (5.14--6.66)   \<0.001     5.45 (4.78--6.22)[a](#tfn2-dmso-10-459){ref-type="table-fn"}   \<0.001

**Notes:**

Adjusted for smoking.

Adjusted for age.

**Abbreviations:** SNHL, sensorineural hearing loss; OR, odds ratio; CI, confidence interval; MetS, metabolic syndrome; BMI, body mass index.

###### 

Associations between potential risk factors and different categories of SNHL

  Variables                                 OR estimates   Patterns                                    
  ----------------------------------------- -------------- --------------------- --------------------- -------------------
  MetS (yes/no)                             OR (95% CI)    1.52 (1.28--1.79)     1.56 (1.35--1.79)     1.22 (1.07--1.40)
  *P*-value                                 \<0.001        \<0.001               \<0.003               
  BMI (overweight/normal weight)            OR (95% CI)    1.31 (1.09--1.58)     1.40 (1.20--1.64)     1.23 (1.06--1.41)
  *P*-value                                 \<0.003        \<0.001               \<0.004               
  BMI (obesity/normal weight)               OR (95% CI)    1.61 (1.31--2.00)     1.55 (1.29--1.86)     1.45 (1.23--1.71)
  *P*-value                                 \<0.001        \<0.001               \<0.001               
  Smoking (yes/no)                          OR (95% CI)    1.93 (1.65--2.27)     1.00 (0.86--1.15)     1.79 (1.58--2.04)
  *P*-value                                 \<0.001        1.00                  \<0.001               
  Duration of driving (10--20/\<10 years)   OR (95% CI)    3.33 (2.40--4.61)     2.53 (1.94--3.30)     1.82 (1.52--2.17)
  *P*-value                                 \<0.001        \<0.001               \<0.001               
  Duration of driving (\>20/\<10 years)     OR (95% CI)    10.92 (8.07--14.77)   10.08 (7.94--12.80)   3.08 (2.60--3.64)
  *P*-value                                 \<0.001        \<0.001               \<0.001               

**Abbreviations:** SNHL, sensorineural hearing loss; MetS, metabolic syndrome; OR, odds ratio; CI, confidence interval; BMI, body mass index.

###### 

Regression coefficients for hearing threshold in the presence of MetS

  Variables                         Unadjusted     Model 1        Model 2        Unadjusted     Model 1        Model 2
  ------------------ -------------- -------------- -------------- -------------- -------------- -------------- ---------
  Presence of MetS   *β*            0.060          0.051          0.059          0.006          0.005          0.005
  95% CI             0.044--0.075   0.037--0.066   0.033--0.066   0.001--0.011   0.001--0.010   0.002--0.010   
  *P*-value          \<0.001        \<0.001        \<0.001        0.014          0.040          0.024          

**Notes:** Model 1 adjusted for age, duration of driving, and smoking. Model 2 adjusted for age, duration of driving, smoking, and BMI.

**Abbreviations:** MetS, metabolic syndrome; low PTA, pure tone average at low frequencies; high PTA, pure tone average at high frequencies; CI, confidence interval; BMI, body mass index.
